Literature DB >> 19451751

Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology.

Nicholas J Zyromski1, Abhishek Mathur, G A Nagana Gowda, Carl Murphy, Deborah A Swartz-Basile, Terence E Wade, Henry A Pitt, Daniel Raftery.   

Abstract

BACKGROUND: Obesity is a worldwide epidemic and a significant risk factor for pancreatic diseases including pancreatitis and pancreatic cancer; the mechanisms underlying this association are unknown. Metabolomics is a powerful new analytical approach for describing the metabolome (compliment of small molecules) of cells, tissue or biofluids at any given time. Our aim was to analyze pancreatic fat content in lean and congenitally obese mice using both metabolomic analysis and conventional chromatography.
METHODS: The pancreatic fat content of 12 lean (C57BL/6J), 12 obese leptin-deficient (Lep(ob)) and 12 obese hyperleptinemic (Lep(db)) mice was evaluated by metabolomic analysis, thin-layer and gas chromatography.
RESULTS: Pancreata of congenitally obese mice had significantly more total pancreatic fat, triglycerides and free fatty acids, but significantly less phospholipids and cholesterol than those of lean mice. Metabolomic analysis showed excellent correlation with thin-layer and gas chromatography in measuring total fat, triglycerides and phospholipids.
CONCLUSIONS: Differences in pancreatic fat content and character may have important implications when considering the local pancreatic proinflammatory milieu in obesity. Metabolomic analysis is a valid, powerful tool with which to further define the mechanisms by which fat impacts pancreatic disease. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451751      PMCID: PMC2790782          DOI: 10.1159/000199436

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  41 in total

1.  Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response.

Authors:  Georgios I Papachristou; Dionysios J Papachristou; Haritha Avula; Adam Slivka; David C Whitcomb
Journal:  Pancreatology       Date:  2006-04-19       Impact factor: 3.996

2.  Effect of a controlled high-fat versus low-fat diet on insulin sensitivity and leptin levels in African-American and Caucasian women.

Authors:  J C Lovejoy; M M Windhauser; J C Rood; J A de la Bretonne
Journal:  Metabolism       Date:  1998-12       Impact factor: 8.694

3.  Monitoring diet effects via biofluids and their implications for metabolomics studies.

Authors:  Haiwei Gu; Huanwen Chen; Zhengzheng Pan; Ayanna U Jackson; Nari Talaty; Bowei Xi; Candice Kissinger; Chester Duda; Doug Mann; Daniel Raftery; R Graham Cooks
Journal:  Anal Chem       Date:  2007-01-01       Impact factor: 6.986

4.  Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort.

Authors:  Alpa V Patel; Carmen Rodriguez; Leslie Bernstein; Ann Chao; Michael J Thun; Eugenia E Calle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

5.  A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha.

Authors:  Takayoshi Suganami; Junko Nishida; Yoshihiro Ogawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

7.  Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.

Authors:  Jung Eun Lee; So Yeon Choi; Wooseong Huh; Yoon-Goo Kim; Dae Joong Kim; Ha Young Oh
Journal:  Am J Hypertens       Date:  2007-11       Impact factor: 2.689

8.  Circulating mononuclear cells in the obese are in a proinflammatory state.

Authors:  Husam Ghanim; Ahmad Aljada; Deborah Hofmeyer; Tufail Syed; Priya Mohanty; Paresh Dandona
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

9.  Fatty pancreas: a factor in postoperative pancreatic fistula.

Authors:  Abhishek Mathur; Henry A Pitt; Megan Marine; Romil Saxena; C Max Schmidt; Thomas J Howard; Attila Nakeeb; Nicholas J Zyromski; Keith D Lillemoe
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

10.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

View more
  15 in total

Review 1.  Deploying mouse models of pancreatic cancer for chemoprevention studies.

Authors:  Paul J Grippo; David A Tuveson
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-02

Review 2.  The clinical significance of pancreatic steatosis.

Authors:  Mark M Smits; Erwin J M van Geenen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

3.  Acute pancreatitis in obesity: adipokines and dietary fish oil.

Authors:  Hayder H Al-Azzawi; Terence E Wade; Deborah A Swartz-Basile; Sue Wang; Henry A Pitt; Nicholas J Zyromski
Journal:  Dig Dis Sci       Date:  2011-02-24       Impact factor: 3.199

4.  Does adiponectin upregulation attenuate the severity of acute pancreatitis in obesity?

Authors:  Hayder H Al-Azzawi; Kathryn M Ziegler; Deborah A Swartz-Basile; Sue Wang; Henry A Pitt; Nicholas J Zyromski
Journal:  J Gastrointest Surg       Date:  2011-06-10       Impact factor: 3.452

5.  Cannabinoid receptor-1 blockade attenuates acute pancreatitis in obesity by an adiponectin mediated mechanism.

Authors:  Nicholas J Zyromski; Abhishek Mathur; Henry A Pitt; Terence E Wade; Sue Wang; Deborah A Swartz-Basile; Andrew D Prather; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2009-02-19       Impact factor: 3.452

6.  Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort.

Authors:  Rachael Z Stolzenberg-Solomon; Catherine Schairer; Steve Moore; Albert Hollenbeck; Debra T Silverman
Journal:  Am J Clin Nutr       Date:  2013-08-28       Impact factor: 7.045

7.  A preoperative predictive score of pancreatic fistula following pancreatoduodenectomy.

Authors:  Keith J Roberts; James Hodson; Homoyoon Mehrzad; Ravi Marudanayagam; Robert P Sutcliffe; Paolo Muiesan; John Isaac; Simon R Bramhall; Darius F Mirza
Journal:  HPB (Oxford)       Date:  2013-11-08       Impact factor: 3.647

8.  Rosiglitazone improves survival and hastens recovery from pancreatic inflammation in obese mice.

Authors:  Maria Pini; Davina H Rhodes; Karla J Castellanos; Robert J Cabay; Eileen F Grady; Giamila Fantuzzi
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

9.  Potential metabolite markers of schizophrenia.

Authors:  J Yang; T Chen; L Sun; Z Zhao; X Qi; K Zhou; Y Cao; X Wang; Y Qiu; M Su; A Zhao; P Wang; P Yang; J Wu; G Feng; L He; W Jia; C Wan
Journal:  Mol Psychiatry       Date:  2011-10-25       Impact factor: 15.992

10.  Spleen-derived interleukin-10 downregulates the severity of high-fat diet-induced non-alcoholic fatty pancreas disease.

Authors:  Koro Gotoh; Megumi Inoue; Kentaro Shiraishi; Takayuki Masaki; Seiichi Chiba; Kimihiko Mitsutomi; Takanobu Shimasaki; Hisae Ando; Kansuke Fujiwara; Isao Katsuragi; Tetsuya Kakuma; Masataka Seike; Toshiie Sakata; Hironobu Yoshimatsu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.